Chemotherapy-induced peripheral neuropathy (CIPN ... and exploring effective treatment options. One promising area of research involves the use of neurofilament light chain (NFL) as a biomarker ...

Four in every 10 cancer patients treated with chemotherapy develop severe peripheral nerve pain, a new evidence review ...

Four in every 10 cancer patients treated with chemotherapy develop severe peripheral nerve pain, a new review suggests.

Chemotherapy has been known to cause damage to peripheral nerves, and sometimes the pain is chronic and severe enough that chemotherapy doses are reduced or discontinued. But prior research has not ...

Worldwide, cancer chemotherapy is linked to persistent severe peripheral nerve pain (neuropathy) for around 4 in every 10 patients treated with these drugs, suggests a pooled data analysis of the ...

BC, CNM, RNFA, spoke about the oncology nurse’s and APP’s roles in managing chemotherapy-induced peripheral neuropathy in ...

Can other treatment options ... induced toxic effects, 66,67 this risk is counterbalanced by the medications used to treat these conditions, which often act as radiosensitisers. For patients who would ...

Subgroup analyses showed that patients treated with platinum-based agents and taxanes had the highest prevalence of chronic ...

Supplements are a popular choice for people with neuropathy, as they can help reduce pain and inflammation, improve nerve function, and promote overall health. However, with so many options on the ...

A further six people have claimed they were given unnecessary chemotherapy after hospital ... have been given temozolomide while receiving treatment from University Hospitals Coventry and ...

While the argatroban trial separated isolated HIT patients (prophylaxis) from HITTS patients (treatment) and the HAT-1 and HAT-2 trials did not, the available meta-analysis for HAT-1 and 2 ...